AKT1 and myotonic dystrophy type 1: Analysis of cell viability following the treatment of myoblasts with different concentrations of senolytics showed that the PI3K/AKT inhibitor Dasatinib + Quercetin, was toxic for cells isolated from both healthy controls and DM1 patients (Supplementary Fig. 8).